Rwanda
GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox